Bullboard Post History

by GoldenInvestor

Order by:

T.GUD	418k+ shares traded! ! March 25, 2024
T.GUD	Morgan Stanley CIO on AI & drug discovery Morgan Stanley CIO on CNBC speaking to how AI can help benefit healthcare via... March 15, 2024
T.GUD	purchase one week out from results Armoyan purchased of approx $700k in GUD shares - why would that be? March 14, 2024
T.GUD	Pharma & Healthcare to be next area of market focus (cnbc) CNBC – 'Half-Time' trader Joe Taranova, Steve Weiscz and 'Pharma&... March 4, 2024
T.GUD	IBS South America article & chronic kidney disease article https://finance.yahoo.com/news/south-central-america-irritable-bowel... February 27, 2024
T.GUD	IBS (potential ( GUD market) in South America market size The South and Central America irritable bowel syndrome (IBS) diagnostics... February 26, 2024
T.GUD	Tenapanor & chronic kidney disease 100 million IBS POTENTIAL people to help with temapanor. also, another... February 26, 2024
T.GUD	Ardelyx reported on thursday Doing well today. GUD for us. February 26, 2024
T.GUD	Market strategists naming healthcare As more and more strategists speaking about broader market being played out &... February 20, 2024
T.GUD	Random unimportant sign via predecessor Apologies, but who knows. dropping off a family member at airport. the... February 7, 2024
T.GUD	Capacity constraints in market Manufacturing is BIGGEST HURDLE for new drugs just discussed on CNBC... February 6, 2024
T.GUD	Demand for innovative new drugs So much demand for innovative new drugs and therapies being talked... February 6, 2024
T.TOY	TD target - $48.00 - highlights from below news TD Investment Conclusion We are increasing our recommendation to... January 24, 2024
T.GUD	Solid results fr J&J incl good pharma growth & medical devic https://www.cnbc.com/2024/01/23/johnson-johnson-jnj-earnings-q4-2023.html... January 23, 2024
T.GUD	Great to see another product LAUNCH TODAY!! Imvexxy launched. More products to end users. January 4, 2024
T.GUD	Qelbree - ADHD - huge opportunity ADHD - more & more kids are affected by this & stand to benefit from... December 19, 2023
T.GUD	Abbvie buying Cerevel for $8.7B A huge premium (~73%) to stock price. showing lots of interest in... December 7, 2023
T.GUD	Abbie to buy Immunogenicity for $10.1 Billion On ovarian cancer drug. great for medical /pharma advances and shows how... November 30, 2023
T.GUD	Ardelyx, portalix biotherapeutics taking off today Investments still held by Knight? November 29, 2023
T.GUD	A respectable quarter for sure! Yes. A respectable quarter! We are seeing the team execute on... November 9, 2023

Become a member today, It's free!

Bullboard Post History

by GoldenInvestor

418k+ shares traded!

Morgan Stanley CIO on AI & drug discovery

purchase one week out from results

Pharma & Healthcare to be next area of market focus (cnbc)

IBS South America article & chronic kidney disease article

IBS (potential ( GUD market) in South America market size

Tenapanor & chronic kidney disease

Ardelyx reported on thursday

Market strategists naming healthcare

Random unimportant sign via predecessor

Capacity constraints in market

Demand for innovative new drugs

TD target - $48.00 - highlights from below news

Solid results fr J&J incl good pharma growth & medical devic

Great to see another product LAUNCH TODAY!!

Qelbree - ADHD - huge opportunity

Abbvie buying Cerevel for $8.7B

Abbie to buy Immunogenicity for $10.1 Billion

Ardelyx, portalix biotherapeutics taking off today

A respectable quarter for sure!

Featured News Links

Do you want to stay ahead of the markets? See how DealRoom can help.

Featured Company

Silvercorp Metals Inc. T.SVM

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by GoldenInvestor

Featured News Links

Featured Company